LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹93 Cr | ₹73 Cr | ₹69 Cr | ₹62 Cr | ₹51 Cr |
What is the latest Profit After Tax of LINCOLN PHARMACEUTICALS ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹93 Cr |
| Mar2024 | ₹73 Cr |
| Mar2023 | ₹69 Cr |
| Mar2022 | ₹62 Cr |
| Mar2021 | ₹51 Cr |
How is Profit After Tax of LINCOLN PHARMACEUTICALS Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹93 Cr | 27.99 | |
| Mar2024 | ₹73 Cr | 5.11 | |
| Mar2023 | ₹69 Cr | 11.41 | |
| Mar2022 | ₹62 Cr | 20.95 | |
| Mar2021 | ₹51 Cr | - | |
Compare Profit After Tax of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,158.0 Cr | -3.6% | -6.1% | 7.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -3.6% |
-6.1% |
7.8% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses